Form 4: RA Capital Increases Stake in 89bio, Inc. Through Share Purchase

RA Capital Management, L.P. has acquired 5,714,285 shares of 89bio, Inc. at $8.75 per share, increasing their total holdings.

Summary

• RA Capital Management, L.P. has reported the acquisition of 5,714,285 shares of 89bio, Inc. common stock.
• The shares were purchased at a price of $8.75 per share.
• This transaction occurred on January 30, 2025.
• Following the transaction, RA Capital's total indirect ownership of 89bio, Inc. common stock is 19,554,319 shares.
• Additionally, RA Capital indirectly holds 335,364 shares through the Nexus Fund.

Sentiment

Score: 7

Explanation: The document indicates a significant investment by a major fund, which is generally a positive sign. However, it's a routine filing, so the sentiment is moderately positive.

Positives

• RA Capital's increased investment suggests confidence in 89bio, Inc.'s future prospects.
• The purchase of a significant number of shares could be seen as a positive signal to the market.

Risks

• The document does not explicitly state any risks, but the investment is subject to market fluctuations and the performance of 89bio, Inc.

Management Comments

• Peter Kolchinsky, Manager of RA Capital Management, L.P., signed the document on behalf of the firm.
• Rajeev Shah, individually, also signed the document.

Industry Context

This filing indicates a significant investment by a major healthcare-focused investment firm, which could signal positive sentiment towards the biotechnology sector and 89bio, Inc. specifically.

Comparison to Industry Standards

• RA Capital's investment is a significant transaction, but without further context, it's difficult to compare to industry standards.
• Other similar biotech investments by RA Capital or other firms would need to be analyzed to determine if this is a typical or unusual transaction.
• The size of the investment and the resulting ownership stake are key factors in assessing its significance.

Stakeholder Impact

• The increased investment by RA Capital could positively impact shareholder confidence.
• The transaction may also influence the perception of 89bio, Inc. among other investors.

Key Dates

Keywords

RA Capital Management, 89bio, share purchase, equity, investment, beneficial ownership, common stock